Information Collection Request

Infant Formula Requirements

ICR 202209-0910-009 · OMB 0910-0256 · Received in OIRA

Forms and Documents
DocumentTypeStatusAvailability
No forms / supporting documents in this ICR. Check IC Document Collections.
IC Document Collections
IC IDCollectionTypeStatusForm
5835 Reports under FFDCA section 412(d) Form and Instruction Unchanged
256173 IC in support of enforcement discretion Other-Agency Guidance New
235376 Exempt Infant Formula Production; GMP; Audits, Records & Records Other-Agency Guidance Unchanged
212199 Part 106; Subpart B - CGMP Requirements (records) Unchanged
212198 New Infant Formula Submission Form and Instruction Unchanged
212197 New Infant Formula Registration Form and Instruction Unchanged
212196 Requirements for Quality Factors -- PER Exemption Form and Instruction Unchanged
212194 Requirements for Quality Factors GMS Exemption Form and Instruction Unchanged
179355 Infant Formula; Labeling (3rd Party Disclosure) Requirements Unchanged
179354 Recordkeeping under Part 106; Subparts C-G - quality control, audits, testing, records Unchanged
179353 Part 107; Subpart C - Exempt Infant Formulas (records) Unchanged
179352 Exempt Infant Formula; Notification Requirements Other-Agency Guidance Unchanged
179351 Reports for exampt Infant Formula Form and Instruction Unchanged
179350 Notifications under 106.120(b) Form and Instruction Unchanged
ICR Details
0910-0256 202209-0910-009
Received in OIRA 202104-0910-013
HHS/FDA CFSAN
Infant Formula Requirements
Revision of a currently approved collection   No
Emergency 09/28/2022
09/28/2022
  Requested Previously Approved
6 Months From Approved 05/31/2024
8,110 7,995
132,715 128,530
0 0

This ICR supports the recordkeeping, reporting, and labeling requirements for the manufacture and distribution of infant formula. Respondents to this collection are infant formula manufacturers who must ensure that their products adhere to the quality control provisions and procedures found in FDA regulations, and that nutrient information and directions for use are disclosed in their product labeling.
FDA is submitting this request memorandum in accordance with 5 CFR 1320.13. As disruptions in the supply of infant formula continue, we are pursuing longer-term information collection pertaining to our exercise of enforcement discretion to provide certain manufacturers a pathway to market covered products that may not currently meet certain applicable requirements. Immediate implementation of the information collection is critical to providing predictability, stability, and continuity in the infant formula market, specifically with respect to products currently available to infants in the U.S. under FDA’s exercise of enforcement discretion. Because we believe that routine procedures allowing for a 60-day comment period would have prevented our ability to immediately implement the information collection, we requested a waiver from the requirement to publish notice in the Federal Register under 5 CFR 1320.13(a)(2)(iii).

US Code: 21 USC 301 et seq. Name of Law: Federal Food, Drug, and Cosmetic Act (FFDCA)
  
None

Not associated with rulemaking
Other Documents for OIRA Review

No

  Total Request Previously Approved Change Due to New Statute Change Due to Agency Discretion Change Due to Adjustment in Estimate Change Due to Potential Violation of the PRA
Annual Number of Responses 8,110 7,995 0 115 0 0
Annual Time Burden (Hours) 132,715 128,530 0 4,185 0 0
Annual Cost Burden (Dollars) 0 0 0 0 0 0
Yes
Miscellaneous Actions
No
FDA is temporarily exercising enforcement discretion with respect to how respondents comply with applicable requirements, including adjustments to existing ways to comply with such requirements (see 5 CFR 1320.3(b)(1)(v)) to address an immediate threat to the public health resulting from the disruption in the supply of necessary products.

$272,773
No
    No
    No
No
No
No
No
Domini Bean 301 796-5733 [email protected]

  No

On behalf of this Federal agency, I certify that the collection of information encompassed by this request complies with 5 CFR 1320.9 and the related provisions of 5 CFR 1320.8(b)(3).
The following is a summary of the topics, regarding the proposed collection of information, that the certification covers:
 
 
 
 
 
 
 
    (i) Why the information is being collected;
    (ii) Use of information;
    (iii) Burden estimate;
    (iv) Nature of response (voluntary, required for a benefit, or mandatory);
    (v) Nature and extent of confidentiality; and
    (vi) Need to display currently valid OMB control number;
 
 
 
If you are unable to certify compliance with any of these provisions, identify the item by leaving the box unchecked and explain the reason in the Supporting Statement.
09/28/2022